Xiao-Mei Huang , Qun Liu , Zhi-Yi Xu , Xiao-Hua Yang , Fan Xiao , Pei-Wen Ouyang , Wan-Zhao Yi , Na zhao , Jing Meng , Yu-Hong Cui , Hong-Wei Pan
{"title":"HuR下调对氧诱导视网膜病变病理性血管生成的抑制作用","authors":"Xiao-Mei Huang , Qun Liu , Zhi-Yi Xu , Xiao-Hua Yang , Fan Xiao , Pei-Wen Ouyang , Wan-Zhao Yi , Na zhao , Jing Meng , Yu-Hong Cui , Hong-Wei Pan","doi":"10.1016/j.exer.2022.109378","DOIUrl":null,"url":null,"abstract":"<div><p><span>HuR (also known as ELAV1), a ubiquitous RNA-binding protein, is implicated in the pathogenesis of diverse diseases<span> via the mechanism of post-transcriptional regulation. Whether it is involved in pathological angiogenesis<span> in oxygen-induced retinopathy is not clear. In this study, we detected HuR expression was increased in the retina of mouse model of oxygen-induced retinopathy (OIR) as well as in </span></span></span>vascular endothelial cells<span> exposed to hypoxia<span><span>. With gain-of-function and loss-of-function studies using adenovirus infection, we found HuR over-expression promoted while HuR knockdown inhibited the migration, proliferation and tube formation of vascular </span>endothelial cells<span><span>. Moreover, HuR regulated the expression of VEGFA in vascular endothelial cells. We also found the retinal pathological angiogenesis in mouse OIR model was greatly reduced with HuR knockdown using recombinant AAV expressing HuR specific shRNA<span><span> which was administered by intravitreal injection. The results of this study suggest HuR is involved in pathological angiogenesis via regulating angiogenic </span>behaviors of endothelial cells, providing a potential target for the </span></span>treatment<span> of retinopathy of prematurity.</span></span></span></span></p></div>","PeriodicalId":12177,"journal":{"name":"Experimental eye research","volume":"227 ","pages":"Article 109378"},"PeriodicalIF":2.7000,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Down-regulation of HuR inhibits pathological angiogenesis in oxygen-induced retinopathy\",\"authors\":\"Xiao-Mei Huang , Qun Liu , Zhi-Yi Xu , Xiao-Hua Yang , Fan Xiao , Pei-Wen Ouyang , Wan-Zhao Yi , Na zhao , Jing Meng , Yu-Hong Cui , Hong-Wei Pan\",\"doi\":\"10.1016/j.exer.2022.109378\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>HuR (also known as ELAV1), a ubiquitous RNA-binding protein, is implicated in the pathogenesis of diverse diseases<span> via the mechanism of post-transcriptional regulation. Whether it is involved in pathological angiogenesis<span> in oxygen-induced retinopathy is not clear. In this study, we detected HuR expression was increased in the retina of mouse model of oxygen-induced retinopathy (OIR) as well as in </span></span></span>vascular endothelial cells<span> exposed to hypoxia<span><span>. With gain-of-function and loss-of-function studies using adenovirus infection, we found HuR over-expression promoted while HuR knockdown inhibited the migration, proliferation and tube formation of vascular </span>endothelial cells<span><span>. Moreover, HuR regulated the expression of VEGFA in vascular endothelial cells. We also found the retinal pathological angiogenesis in mouse OIR model was greatly reduced with HuR knockdown using recombinant AAV expressing HuR specific shRNA<span><span> which was administered by intravitreal injection. The results of this study suggest HuR is involved in pathological angiogenesis via regulating angiogenic </span>behaviors of endothelial cells, providing a potential target for the </span></span>treatment<span> of retinopathy of prematurity.</span></span></span></span></p></div>\",\"PeriodicalId\":12177,\"journal\":{\"name\":\"Experimental eye research\",\"volume\":\"227 \",\"pages\":\"Article 109378\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2023-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Experimental eye research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0014483522004596\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental eye research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0014483522004596","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
Down-regulation of HuR inhibits pathological angiogenesis in oxygen-induced retinopathy
HuR (also known as ELAV1), a ubiquitous RNA-binding protein, is implicated in the pathogenesis of diverse diseases via the mechanism of post-transcriptional regulation. Whether it is involved in pathological angiogenesis in oxygen-induced retinopathy is not clear. In this study, we detected HuR expression was increased in the retina of mouse model of oxygen-induced retinopathy (OIR) as well as in vascular endothelial cells exposed to hypoxia. With gain-of-function and loss-of-function studies using adenovirus infection, we found HuR over-expression promoted while HuR knockdown inhibited the migration, proliferation and tube formation of vascular endothelial cells. Moreover, HuR regulated the expression of VEGFA in vascular endothelial cells. We also found the retinal pathological angiogenesis in mouse OIR model was greatly reduced with HuR knockdown using recombinant AAV expressing HuR specific shRNA which was administered by intravitreal injection. The results of this study suggest HuR is involved in pathological angiogenesis via regulating angiogenic behaviors of endothelial cells, providing a potential target for the treatment of retinopathy of prematurity.
期刊介绍:
The primary goal of Experimental Eye Research is to publish original research papers on all aspects of experimental biology of the eye and ocular tissues that seek to define the mechanisms of normal function and/or disease. Studies of ocular tissues that encompass the disciplines of cell biology, developmental biology, genetics, molecular biology, physiology, biochemistry, biophysics, immunology or microbiology are most welcomed. Manuscripts that are purely clinical or in a surgical area of ophthalmology are not appropriate for submission to Experimental Eye Research and if received will be returned without review.